JP2010502582A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502582A5
JP2010502582A5 JP2009526177A JP2009526177A JP2010502582A5 JP 2010502582 A5 JP2010502582 A5 JP 2010502582A5 JP 2009526177 A JP2009526177 A JP 2009526177A JP 2009526177 A JP2009526177 A JP 2009526177A JP 2010502582 A5 JP2010502582 A5 JP 2010502582A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
aryl
alkynyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009526177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502582A (ja
JP5506386B2 (ja
Filing date
Publication date
Priority claimed from GB0617278A external-priority patent/GB0617278D0/en
Priority claimed from GB0625929A external-priority patent/GB0625929D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/003302 external-priority patent/WO2008029096A2/en
Publication of JP2010502582A publication Critical patent/JP2010502582A/ja
Publication of JP2010502582A5 publication Critical patent/JP2010502582A5/ja
Application granted granted Critical
Publication of JP5506386B2 publication Critical patent/JP5506386B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009526177A 2006-09-04 2007-09-04 Ｐ５３活性化化合物 Expired - Fee Related JP5506386B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0617278A GB0617278D0 (en) 2006-09-04 2006-09-04 P53 activating compounds
GB0617278.7 2006-09-04
GB0625929.5 2006-12-23
GB0625929A GB0625929D0 (en) 2006-12-23 2006-12-23 P53 activating compounds
PCT/GB2007/003302 WO2008029096A2 (en) 2006-09-04 2007-09-04 P53 activating benzoyl urea and benzoyl thiourea compounds

Publications (3)

Publication Number Publication Date
JP2010502582A JP2010502582A (ja) 2010-01-28
JP2010502582A5 true JP2010502582A5 (https=) 2010-10-21
JP5506386B2 JP5506386B2 (ja) 2014-05-28

Family

ID=38819391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526177A Expired - Fee Related JP5506386B2 (ja) 2006-09-04 2007-09-04 Ｐ５３活性化化合物

Country Status (6)

Country Link
US (2) US8501991B2 (https=)
EP (1) EP2099445B1 (https=)
JP (1) JP5506386B2 (https=)
AT (1) ATE488232T1 (https=)
DE (1) DE602007010664D1 (https=)
WO (1) WO2008029096A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2952522B1 (en) 2007-01-31 2019-10-30 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
US8952028B2 (en) 2007-02-05 2015-02-10 City Of Hope Methods of treating chemoresistance and relapse in cancer cells
US8580488B2 (en) * 2007-02-05 2013-11-12 City Of Hope Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
AU2008232709C1 (en) 2007-03-28 2015-01-15 President And Fellows Of Harvard College Stitched polypeptides
WO2008138943A2 (en) * 2007-05-14 2008-11-20 Universite Libre De Bruxelles Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
FR2930552B1 (fr) * 2008-04-24 2012-10-12 Centre Nat Rech Scient N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
WO2011022028A2 (en) * 2009-05-18 2011-02-24 Tufts University Small molecule antagonists of phosphatidylinositol-3, 4, 5-triphosphate (pip3) and uses thereof
GB0909912D0 (en) 2009-06-09 2009-07-22 Univ Dundee Compounds
EP2536286A4 (en) * 2010-02-19 2013-11-13 Siga Technologies Inc INHIBITORS AND METHOD FOR INHIBITING BACTERIAL AND VIRAL DISEASES
KR20170058446A (ko) 2010-08-13 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
US10016414B2 (en) 2010-11-12 2018-07-10 University Of Massachusetts Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
FR2980477B1 (fr) * 2011-09-23 2013-10-18 Centre Nat Rech Scient Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
AR088392A1 (es) 2011-10-18 2014-05-28 Aileron Therapeutics Inc Macrociclos peptidomimeticos
CA2862038C (en) 2012-02-15 2021-05-25 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
BR112015009470A2 (pt) 2012-11-01 2019-12-17 Aileron Therapeutics Inc aminoácidos dissubstituídos e seus métodos de preparação e uso
CN105392788B (zh) * 2013-05-13 2018-10-23 葛兰素史密斯克莱有限责任公司 用作沉默调节蛋白调节剂的取代的桥连脲类似物
SG11201702175YA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and formulations thereof
WO2016049359A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10253067B2 (en) 2015-03-20 2019-04-09 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子
CN115724780B (zh) * 2022-11-17 2024-04-26 武汉大学 一种基于疏水标签的酰基硫脲类化合物及其制备方法与抗甲型流感病毒的应用
CN117069631A (zh) * 2023-08-15 2023-11-17 北京中医药大学 一种具有抗肿瘤活性的新型硫脲类化合物及其制备方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116728B1 (en) * 1983-01-24 1987-08-12 Duphar International Research B.V Composition active against mites, whitefly and thrips, pharmaceutical composition, and new benzoylureau compounds
EP0117320B1 (en) * 1983-01-24 1987-03-04 Duphar International Research B.V Benzoylurea compounds, and pesticidal compositions comprising same
DE3478573D1 (en) * 1983-09-01 1989-07-13 Duphar Int Res Benzoyl urea derivatives having anti-tumor activity
AU601145B2 (en) * 1985-03-01 1990-09-06 Duphar International Research B.V. Benzoyl urea derivatives having anti-tumor activity
AU642524B2 (en) 1990-09-10 1993-10-21 Duphar International Research B.V. Pharmaceutical formulation containing a benzoyl urea derivative
JPH05247001A (ja) * 1991-12-05 1993-09-24 Ishihara Sangyo Kaisha Ltd 置換ベンゾイルウレア誘導体又はその塩、それらの製造方法及びそれらを含有する抗癌剤
KR950026862A (ko) * 1994-03-15 1995-10-16 강박광 벤조일 우레아 유도체
JPH07285952A (ja) * 1994-04-08 1995-10-31 Fujisawa Pharmaceut Co Ltd 新規複素環誘導体
US20060004085A1 (en) * 2002-03-29 2006-01-05 University Of Maryland , Baltimore Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same
ES2295672T3 (es) * 2002-08-07 2008-04-16 Neuraxon Inc. Compuestos de aminobenzotiazol con actividad inhibitoria de la oxido nitrico sintasa (nos).
US7087761B2 (en) * 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006110762A2 (en) 2005-04-11 2006-10-19 Achillion Pharmaceutical compositions for and methods of inhibiting hcv replication

Similar Documents

Publication Publication Date Title
JP2010502582A5 (https=)
BRPI0516284A (pt) anticorpo construìdo com cisteìna, método de selecionar anticorpos, compostos conjugados de droga-anticorpo, composição farmacêutica, método para matar ou inibir a proliferação de células de tumor, métodos de inibir a proliferação celular e o crescimento de células de tumor, artigo manufaturado e método para produzir um composto
AU2015320792A1 (en) Methods of treating liver disease
US20260070947A1 (en) Cyclic cell-penetrating peptide compounds
JP6155193B2 (ja) ヒト免疫不全ウイルスに対する抗体動員及び進入阻害活性を有する二官能性分子
JP2009537461A5 (https=)
KR20200015528A (ko) 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
KR20200035982A (ko) 의학적 장애의 예방 및 치료를 위한 화합물 및 이의 용도
AU2019366819A1 (en) Biomarkers of MetAP2 inhibitors and applications thereof
US20230382945A1 (en) Therapeutic agents and methods
EP4294820A1 (en) Cyclic cell-penetrating peptides with three or more hydrophobic residues
JP7777263B2 (ja) ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法
RU2020108281A (ru) Новые ацилированные аналоги инсулина и варианты их применения
JP4939396B2 (ja) Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
JP2010523632A5 (https=)
US10787413B2 (en) Derivatives of curcuminoids and use thereof as an anticancer agent
CN104546819A (zh) 二咖啡酰奎宁酸在治疗系统性自身免疫性疾病中的用途
CN110963996A (zh) 含苯乙酮取代基的靛红唑醇类化合物及其制备方法和医药应用
TW201010988A (en) 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
CN103965193A (zh) N-(苯氧烷基)咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法
Le et al. Thiazole conjugated amino acid derivatives as potent cytotoxic agents
JP2004536109A5 (https=)
HK40111445A (zh) 定向淋巴的前药
CN1259314C (zh) 亲水性聚合物－黄酮结合物以及包含该结合物的药物组合物
HK40012742A (en) Methods of treating liver disease